Orca Bio
Sarah Silvers, MS, RQAP-GCP, currently serves as the Head of Clinical QA at Orca Bio, following a tenure as Senior Director of Clinical Quality Assurance at Tenaya Therapeutics. With extensive experience in clinical quality assurance, Sarah has held senior leadership roles at SanBio, Inc., and Catalyst Clinical Research, LLC, where responsibilities included leading regulatory inspections and overseeing quality aspects of clinical trials. Early career experience includes roles at Purdue Pharma, POZEN, and Amgen, Inc., with a strong focus on GCP compliance and quality management. Sarah holds multiple degrees, including an M.S. in Regulatory Science from the University of Southern California and a BS in Cell and Molecular Biology and Chemistry from Kansas State University.
This person is not in any teams
This person is not in any offices
Orca Bio
3 followers
Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Their manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling them to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Their talented team is driven by a passion for science and compassion for patients.